The review found no eligible studies for this question.
Propafenone probably leads to higher withdrawals due to adverse effects compared with placebo or no treatment (moderate certainty).
Flecainide showed no clear difference in withdrawals due to adverse effects compared with placebo or no treatment (low certainty).
Quinidine showed no clear difference in withdrawals due to adverse effects compared with placebo or no treatment (moderate certainty).
Metoprolol leads to higher withdrawals due to adverse effects compared with placebo or no treatment (high certainty).
Amiodarone may leads to higher withdrawals due to adverse effects compared with placebo or no treatment (low certainty).
Dofetilide showed no clear difference in withdrawals due to adverse effects compared with placebo or no treatment (low certainty).
Dronedarone probably leads to higher withdrawals due to adverse effects compared with placebo or no treatment (moderate certainty).
Sotalol probably leads to higher withdrawals due to adverse effects compared with placebo or no treatment (moderate certainty).
Disopyramide showed no clear difference in withdrawals due to adverse effects compared with placebo or no treatment (low certainty).
Uric acid‐lowering drug showed no clear difference in adverse events (withdrawals due to side effects) compared with placebo (low certainty).
Antihypertensive drug may leads to higher withdrawals due to adverse effects Mean duration of 4.6 years compared with placebo or no treatment (low certainty).
Calcium channel blockers showed no clear difference in number of withdrawals due to adverse events Number of participants… compared with placebo (low certainty).